SCHEMBL7717439

SCHEMBL7717439

CO[C@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 8/20 0.62
▸ LGALS8 O00214 3/20 0.62
▸ LGALS4 P56470 1/20 0.62
▸ LGALS7; LGALS7B P47929 3/20 0.55
▸ LGALS1 P09382 1/20 0.55
▸ LGALS9 O00182 3/20 0.53
▸ CD69 Q07108 1/20 0.52
▸ CHIA Q9BZP6 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ MAPK1 P28482 1/20 0.47
▸ FGF1 P05230 1/20 0.46
▸ FGF2 P09038 1/20 0.46
▸ VEGFA P15692 1/20 0.46
▸ HPSE Q9Y251 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7717434 1.00 LGALS3 (0.62) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL18966050 0.97 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL17945670 0.97 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL17955020 0.97 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL17950825 0.97 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL21134603 0.97 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL23613765 0.95 LGALS3 (0.64) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL26334737 0.95 LGALS3 (0.64) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL18122370 0.94 LGALS3 (0.66) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL16407357 0.93 LGALS3 (0.64) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020142046-A1 Protein particles for therapeutic and diagnostic use YEN, RICHARD C.K. 2002-10-03 — — US disclosed
US-6391343-B1 PARTICLE COMPRISING FIBRINOGEN BOUND ON SURFACE OF ALBUMIN MATRIX, CAPABLE OF CO-AGGREGATION WITH PLATELETS, AND OF AGGREGATION IN SOLUTION CONTAINING SOLUBLE FIBRINOGEN AT CONCENTRATION NOT CAPABLE OF CLOT FORMATION BY ITSELF HEMOSPHERE, INC. 2002-05-21 — — US disclosed
US-5945033-A ALBUMIN, HEMOGLOBIN MIXTURE; STABILITY HEMOSPHERE, INC. (US) 1999-08-31 — — US disclosed
US-5725804-A ALBUMIN PARTICLES STABLE TO RESOLUBILIZATION, POLYOXYETHYLENE GLYCOL, ALCOHOL HEMOSPHERE, INC. (US) 1998-03-10 — — US disclosed
US-5616311-A AQUEOUS ALBUMIN SUSPENSION STABILIZED BY HEMOGLOBIN PARTICLES HEMOSPHERE, INC. (US) 1997-04-01 — — US disclosed
EP-0126043-B1 CARBOHYDRATE DERIVATIVES AND COMPOSITIONS THEREOF FOR THERAPEUTIC OR DIAGNOSTIC USE ANDERSSON, Bengt (SE) 1989-10-25 — — EP disclosed
Send feedback